Alaunos Therapeutics, Inc.
TCRTNasdaqCIK 1107421HealthcareFiscal year ends Dec 31
Reports and events: 433 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2316:30 ET | 8-K | 8.01 Other events | 0001193125-26-430507 |
| 2026-10-2120:30 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001193125-26-427890 |
| 2026-10-1523:55 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193805-26-001370 |
| 2026-10-1520:01 ET | SCHEDULE 13D | Ownership report, active investor | 0001683168-26-007898 |
| 2026-10-1313:28 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-419829 |
| 2026-10-0920:30 ET | 8-K | 3.01 Delisting notice | 0001193125-26-419154 |
| 2026-09-2220:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-397996 |
| 2026-09-1701:03 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws | 0001193125-26-393462 |
| 2026-08-1420:31 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-352421 |
| 2026-06-2912:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-286914 |
| 2026-05-2615:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-238237 |
| 2026-05-1812:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-227921 |
| 2026-05-1521:29 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-227272 |
| 2026-04-3021:14 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001193125-26-197838 |
| 2026-04-1520:32 ET | 8-K | 3.01 Delisting notice | 0001193125-26-157126 |
| 2026-03-3120:33 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-134720 |
| 2026-03-0516:33 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0002094682-26-000002 |
| 2026-03-0211:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-084084 |
| 2026-02-2421:56 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0002094682-26-000001 |
| 2026-01-0813:30 ET | 8-K | 1.02 Termination of a material agreement; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-007054 |
| 2025-12-2322:18 ET | 8-K | 8.01 Other events | 0001193125-25-331147 |
| 2025-12-0520:20 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0002094682-25-000003 |
| 2025-11-1421:15 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-282988 |
| 2025-10-3118:13 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0002094682-25-000002 |
| 2025-10-3022:48 ET | SCHEDULE 13D | Ownership report, active investor | 0002094682-25-000001 |
| 2025-10-2223:25 ET | S-1 | Registration statement | 0001193125-25-245483 |
| 2025-09-0521:20 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-25-085149 |
| 2025-08-2021:15 ET | 8-K | 8.01 Other events | 0000950170-25-110484 |
| 2025-08-1420:15 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-108887 |
| 2025-07-2220:45 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-097591 |
| 2025-07-1721:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-096656 |
| 2025-07-1020:30 ET | 8-K | 3.03 Change to security holders’ rights; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-095029 |
| 2025-07-0221:30 ET | 8-K | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors | 0000950170-25-093263 |
| 2025-07-0123:40 ET | SCHEDULE 13D | Ownership report, active investor | 0000921895-25-001912 |
| 2025-06-2612:45 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-090202 |
| 2025-06-2612:45 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-25-090201 |
| 2025-06-1021:52 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-25-083913 |
| 2025-05-2321:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-25-077064 |
| 2025-05-2112:42 ET | DEF 14A | Proxy statementPeriod 2025-07-03 | 0001193125-25-123677 |
| 2025-05-1520:27 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-072709 |
| 2025-05-1418:59 ET | SCHEDULE 13D | Ownership report, active investor | 0001213900-25-043211 |
| 2025-04-3020:59 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0000950170-25-061207 |
| 2025-04-1820:45 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-055903 |
| 2025-04-1521:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-054309 |
| 2025-04-1413:15 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-25-053523 |
| 2025-04-1120:45 ET | 8-K | 3.01 Delisting notice; 8.01 Other events | 0000950170-25-053325 |
| 2025-03-3120:18 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-047758 |
| 2024-11-1414:30 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-126793 |
| 2024-10-1012:30 ET | 8-K | 1.02 Termination of a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-113960 |
| 2024-08-1420:54 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-097142 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:04 ET. Listed shows no prices and gives no investment advice.